03736naa a22005537i 4500001002500000003000600025005001700031006001900048007001500067008004100082024003500123035003200158040002200190041000800212100003700220245017100257264007200428300003500500336002600535337002600561338003600587500003800623500004800661506011200709520129000821540015102111546001602262588012802278590005802406650001802464650001502482650001902497650002202516650000902538653003802547653003202585653001602617655002102633700002302654700003602677700004002713700003002753700004602783773010002829856009302929884013903022942000603161999001503167UMUN-OA-20261005-MLS-061local20261005174906.0m o d cr||||||||||||261005s2022 xx o u000 0 eng d7 a10.3389/fbioe.2022.9227722doi a(local)EuropePMC:PMC9237331 alocalbengclocal0 aeng0 aAndreea-Cristina Miricaeauthor.10aLatest Trends in Lateral Flow Immunoassay (LFIA) Detection Labels and Conjugation Process. /cAndreea-Cristina Mirica; Dana Stan; Ioana-Cristina Chelcea [and others]. 1a[Place of publication not identified] :bFrontiers Media SA,c2022. a1 online resource (1 article). atextbtxt2rdacontent acomputerbc2rdamedia aonline resourcebcr2rdacarrier aPublication type: Review article. aLinked open-access copy: published version.0 aOpen access; no subscription required for the linked open-access version.fUnrestricted online access2star3 aLFIA is one of the most successful analytical methods for various target molecules detection. As a recent example, LFIA tests have played an important role in mitigating the effects of the global pandemic with SARS-COV-2, due to their ability to rapidly detect infected individuals and stop further spreading of the virus. For this reason, researchers around the world have done tremendous efforts to improve their sensibility and specificity. The development of LFIA has many sensitive steps, but some of the most important ones are choosing the proper labeling probes, the functionalization method and the conjugation process. There are a series of labeling probes described in the specialized literature, such as gold nanoparticles (GNP), latex particles (LP), magnetic nanoparticles (MNP), quantum dots (QDs) and more recently carbon, silica and europium nanoparticles. The current review aims to present some of the most recent and promising methods for the functionalization of the labeling probes and the conjugation with biomolecules, such as antibodies and antigens. The last chapter is dedicated to a selection of conjugation protocols, applicable to various types of nanoparticles (GNPs, QDs, magnetic nanoparticles, carbon nanoparticles, silica and europium nanoparticles). aCreative Commons Attribution (licence family recorded by the source; version not supplied in metadata).uhttps://europepmc.org/articles/PMC9237331 aIn English.0 aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source. aCourse allocation: B. Sc. Medical Laboratory Science. 4aNanoparticles 4aDiagnostic 4aBioconjugation 4aFunctionalization 4aLfia aB. Sc. Medical Laboratory Science aUMUN open access collection aimmunoassay 4aReview articles.0 aDana Staneauthor.0 aIoana-Cristina Chelceaeauthor.0 aCarmen Marinela Mihailescueauthor.0 aAugustin Ofiterueauthor.0 aLorena-Andreea Bocancia-Mateescueauthor.0 tFrontiers in bioengineering and biotechnologygVol. 10, (2022), pages/article 922772x2296-418540uhttps://europepmc.org/articles/PMC9237331yRead open-access publicationzOpen access.70 aCourse selection and automated MARC21 enrichment from Europe PMC metadata.g20261005khttps://europepmc.org/articles/PMC9237331qlocal n0 c1203d1203